A Platform for Rationally Designing and Controlled Manufacturing of Complex Consortia Products that combine the Functional Diversity and Activity of Healthy Microbiomes with Scalable, Consistent and MoA-targeted Consortia
Time: 1:00 pm
day: Conference Day Two, Track One, PM
Details:
- Enabling precise identification and quantification of individual strains within complex consortia, allowing for potency assessment and process control in manufacturing
- Addressing co-culture challenges by stabilizing microbial communities through rational product design and advanced fermentation strategies
- Ensuring scalability, reproducibility, and quality control of high-diversity microbial therapeutics
- Strategically integrating strain-specific mechanisms with host-microbiome interactions
